Actavis' Generic Lialda Still Too Early, Judge Finds
A Florida federal judge on Monday barred Actavis from launching its generic version of Shire's inflammatory bowel disease treatment Lialda until the patent for the drug expires in June 2020, following...To view the full article, register now.
Already a subscriber? Click here to view full article